Effect of intraoperative application of remifentanil on postoperative pain: A prospective clinical study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200061363

Enrollment

Unknown

Registered

2022-06-22

Start date

2022-06-13

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain

Interventions

intraoperative application of remifentanil group:Nil

non remifentanil group:Nil

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age >18 years, ASA physical status ?-?, patients undergoing general anesthesia with endotracheal intubation or laryngeal mask placement

Exclusion criteria

Exclusion criteria: Allergy to any drug used for anesthesia; pregnancy or lactation;emergency surgery;patients with chronic intake of benzodiazepines or opioids;patients with chronic pain; patients with heart, kidney and liver failure; general anesthesia combined with nerve block or intrathecal anesthesia;demand of patient-controlled analgesia (PCA);patients unable to perform pain assessment methods; Patients reject to participate.

Design outcomes

Primary

Measure	Time frame
severity of postoperative pain;	—

Secondary

Measure	Time frame
provoked hyperalgesia;	—

Countries

China

Contacts

Public ContactJiehao Sun

sun_jiehao@126.com+86 13676721930

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026